NEW YORK STATE COMMON RETIREMENT FUND - ASCENDIS PHARMA A/S ownership

ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 164 filers reported holding ASCENDIS PHARMA A/S in Q3 2023. The put-call ratio across all filers is 1.12 and the average weighting 0.6%.

Quarter-by-quarter ownership
NEW YORK STATE COMMON RETIREMENT FUND ownership history of ASCENDIS PHARMA A/S
ValueSharesWeighting
Q3 2023$19,168
+4.9%
204,700
-0.0%
0.03%
+21.7%
Q2 2023$18,270
-31.4%
204,703
-17.6%
0.02%
-36.1%
Q1 2023$26,646
-14.6%
248,521
-2.7%
0.04%
-16.3%
Q4 2022$31,205
-99.9%
255,506
-8.1%
0.04%
+2.4%
Q3 2022$28,718,000
+13.1%
278,117
+1.8%
0.04%
+27.3%
Q2 2022$25,396,000
-27.1%
273,198
-8.0%
0.03%
-10.8%
Q1 2022$34,835,000
-9.6%
296,823
+3.6%
0.04%
-5.1%
Q4 2021$38,547,000
-27.4%
286,532
-14.0%
0.04%
-31.6%
Q3 2021$53,097,000
+41.8%
333,129
+17.0%
0.06%
+46.2%
Q2 2021$37,448,000
+5.1%
284,668
+3.0%
0.04%0.0%
Q1 2021$35,619,000
-21.1%
276,377
+2.0%
0.04%
-22.0%
Q4 2020$45,171,000
+1.8%
270,842
-5.8%
0.05%
-7.4%
Q3 2020$44,393,000
+18.1%
287,666
+13.2%
0.05%
+12.5%
Q2 2020$37,590,000
+22.3%
254,155
-6.9%
0.05%
+4.3%
Q1 2020$30,741,000
-14.0%
272,984
+6.2%
0.05%
+7.0%
Q4 2019$35,765,000
+40.5%
257,083
-2.7%
0.04%
+34.4%
Q3 2019$25,456,000
-17.1%
264,283
-0.9%
0.03%
-15.8%
Q2 2019$30,705,000
+11.9%
266,648
+14.4%
0.04%
+8.6%
Q1 2019$27,430,000
+87.9%
233,048
-0.0%
0.04%
+66.7%
Q4 2018$14,601,000
+27.7%
233,049
+44.4%
0.02%
+50.0%
Q3 2018$11,436,000
+42.5%
161,393
+33.7%
0.01%
+40.0%
Q2 2018$8,028,000
+19.4%
120,691
+17.4%
0.01%
+25.0%
Q1 2018$6,726,000102,8390.01%
Other shareholders
ASCENDIS PHARMA A/S shareholders Q3 2023
NameSharesValueWeighting ↓
RA Capital Management 5,909,742$911,991,00016.68%
Vivo Capital, LLC 1,797,745$277,428,00016.03%
Sofinnova Investments, Inc. 1,109,874$171,276,00012.70%
Asymmetry Capital Management, L.P. 81,442$12,568,0008.08%
Ghost Tree Capital, LLC 130,000$20,062,0005.80%
Eversept Partners, LP 161,004$24,846,1375.52%
Eventide Asset Management 1,709,848$263,864,0005.16%
Avoro Capital Advisors LLC 1,800,000$277,776,0003.95%
BERYLSON CAPITAL PARTNERS, LLC 72,700$11,219,0003.93%
Spyglass Capital Management LLC 547,022$84,416,0003.90%
View complete list of ASCENDIS PHARMA A/S shareholders